Neuropathology and Cognitive Scores Workgroup The role of vascular and Alzheimer’s Disease pathology in differential cognitive impairment among older adults.

Slides:



Advertisements
Similar presentations
WMS-IV Wechsler Memory Scale - Fourth Edition
Advertisements

Designing Accessible Reading Assessments National Accessible Reading Assessment Projects General Advisory Committee December 7, 2007 Overview of DARA Project.
Longitudinal Relationship of Cognitive Functioning with Depressive Symptoms in Older Adults Archana Jajodia, Ph.D. University of Southern California.
It is common practice for Neuropsychologists to administer the same tests on more than one occasion to document the progression of a patient’s cognitive.
MGT-491 QUANTITATIVE ANALYSIS AND RESEARCH FOR MANAGEMENT
The Technology-Rich Outcomes-Focused Learning Environment Inventory (TROFLEI): A Cross-Cultural Validation Anita Welch, Claudette Peterson, Chris Ray,
David Wechsler's Intelligence Scale Jesse Jones Arith Wijesinha Jack Brown Troy Nicholson.
Growth Mixture Modeling Workgroup Heterogeneous trajectories of cognitive decline: Association with neuropathology Hayden K., Reed B., Chelune G., Manly.
Copyright © 2008 Pearson Education, inc. or its affiliates. All rights reserved. An Introduction to Advanced Clinical Solutions for the WAIS-IV and WMS-IV.
Developing and validating a stress appraisal measure for minority adolescents Journal of Adolescence 28 (2005) 547–557 Impact Factor: A.A. Rowley.
Dynamic Changes in Cognitive Activity and Global Cognition in the Memory and Aging Project Members (in alphabetical order): Amber, David, Doug, Emily,
Participants  Thirty-five children completed both waves of data collection (18 female, 17 male)  1 male was diagnosed with autism spectrum disorder between.
Life course model of cognitive reserve Advanced Psychometrics Methods Web Conference – 2/16/10.
Neuropsychological Testing Neuropsychological Testing, Continued: Multi-dimensional assessment.
Screening By building screening for symptoms of VCI into regular workflows or practice, health care providers are participating in Taking Action to address.
The New Brief Cognitive Assessment Tool (BCAT): The Role of Cognitive Assessment in Improving Health Outcomes Dr. William Mansbach October 25, 2011.
Mild Cognitive Impairment as a Target for Drug Development Steven H. Ferris, Ph.D. Silberstein Aging and Dementia Research Center New York University School.
Alexander I. Tröster, Ph.D. Department of Neurology
Mild Cognitive Impairment
MCI Clinical Trial Design FDA Advisory Committee Meeting March 13, 2001 Gaithersburg, MD Michael Grundman, MD, MPH Alzheimer’s Disease Cooperative Study.
Author: Sabrina Hinton. Year and Publisher: American Guidance Service.
Fractionation of Memory in Medial Temporal Lobe Amnesia
Multivariate Methods EPSY 5245 Michael C. Rodriguez.
Screening for Stroke and Cognitive Impairment Chapter 2: Background.
Multiple Sample Models James G. Anderson, Ph.D. Purdue University.
Wechsler Adult Intelligence Scales
TM 1.
Epidemiology of Dementia: the MoVIES Project Alzheimer’s Disease Patient Registry (ADPR ), University of Pittsburgh Initially funded by NIA under.
New Learning and Remote Memory in Atypical Alzheimer’s Disease Yvonne Rogalski EXP 4504 December 3 rd, 2007 Thompson, Beswick, Foster, & Snowden (2003)
Naglieri Nonverbal Ability Test (NNAT) Miami-Dade County Public Schools NNAT Workshop March 26, 28, & 29, 2007.
A Program of Research Examining the Cognitive Correlates of Methamphetamine Abuse.
IQ Testing & Brain Damage. Full Scale IQ Person’s relative standing in comparison w/ age- related peers and global estimate of overall mental abilities.
MEMORY ASSESSMENT in the LAB vs. the CLINIC
Procedures Manual, Control Series, & Phenotype Committee Update Stephanie Doan, MPH NIA AD Genetics Initiative Co-Coordinator Columbia University.
A Framework of Mathematics Inductive Reasoning Reporter: Lee Chun-Yi Advisor: Chen Ming-Puu Christou, C., & Papageorgiou, E. (2007). A framework of mathematics.
Competency in Older Adults: Clinical and Legal Perspectives The Role of Cognitive and Neuropsychological Evaluations John Crumlin, PhD Assistant Director,
Cognitive Development Across Adulthood Lecture 11/29/04.
Friday Harbor Psychometrics 2012 Scientific Summary UC Davis / SENAS (Spanish and English Neuropsychological Assessment Scales)
From Bad to Worse: Variations in Judgments of Associative Memory Erin Buchanan, Ph.D., Missouri State University Abstract Four groups were tested in variations.
INTRODUCTION Previous literature suggests that schizophrenia is characterized by a disturbed, fragmented and/or poorly elaborated personal identity (e.g.,
Process Approach to Detecting Early Cognitive Impairment Rhoda Au, Ph.D., Friday Harbor 9/14/15 MBA.
JAM-boree: A Meta-Analysis of Judgments of Associative Memory Kathrene D. Valentine, Erin M. Buchanan, Missouri State University Abstract Judgments of.
Assessment/tests/measures Semantics??. “Definitions” n “Assessment” -- the gathering and integration of psychological-related data for the purpose of.
The Self-Compassion Scale (SCS) is the primary measure of self- compassion in both social/personality psychology and clinical research (Neff, 2003). It.
Chapter 6 - Standardized Measurement and Assessment
Background. Vascular Cognitive Impairment Vascular Cognitive Impairment (VCI) includes the cognitive and behavioural disorders associated with cerebrovascular.
Older adults generally perform worse than younger adults on tests of episodic long-term memory, but show preserved performance on tests of semantic memory.
Identifying and Tracking Changes in Cognition Related to NPH Sheldon Herring, Ph.D. Clinical Director Outpatient Brain Injury and Young Stroke Program.
Mild Cognitive Impairment, Activity Participation, Functional Difficulty, and Adaptations in Functionally Vulnerable Elderly People: A Closer Look Laraine.
The influence of forgetting rate on complex span and academic performance Debbora Hall, Chris Jarrold, John Towse and Amy Zarandi.
The Clinical Utility of the LANSE- A and LANSE-C Jennifer L. Harrison, M.A., Megan Pollock, M.A., Amy Mouanoutoua, M.A. Ashley Brimager, M.A., & Paul C.
Results Results Dillon C, MD, PhD; Vazquez G, MD, PhD ; Corrales A, MD; Allegri RF, MD, PhD; Taragano FE, MD, PhD. CEMIC University Hospital, SIREN, Department.
Consistency and Meaningfulness Ensuring all efforts have been made to establish the internal validity of an experiment is an important task, but it is.
NAEP What is it? What can I do with it? Kate Beattie MN NAEP State Coordinator MN Dept of Education This session will describe what the National Assessment.
Date of download: 7/8/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Intranasal Insulin Therapy for Alzheimer Disease and.
All Hands Meeting 2004 Ontologies for Data Mediation Christine Fennema-Notestine, Ph.D.
C-Reactive Protein & Cognitive Function
Rachel L. Fazio, Psy. D. , Allison N. Faris, Psy. D. , Karim Z
Cognitive Biomarker of MS
Do as I Do, Not as I Say; Relations Between Narrative Script Production and Everyday Action Benjamin L. Deck, Ashley Hagerty, Emily Roll, Tania Giovannetti,
Bowden, Shores, & Mathias (2006): Failure to Replicate or Just Failure to Notice. Does Effort Still Account for More Variance in Neuropsychological Test.
Cognitive Data in the Parkinson’s Progression Marker Initiative: Comparison of Normative Data Approaches Kathryn A. Wyman-Chick, Matthew J. Barrett, Phillip.
The involvement of visual and verbal representations in a quantitative and a qualitative visual change detection task. Laura Jenkins, and Dr Colin Hamilton.
Brief Visuospatial Memory Test- Revised™ (BVMT-R™) Ralph H
Using reinforcement-based models of transitive inference
New Face-Name Paradigm for Patients with Mild Alzheimer’s Disease
EPSY 5245 EPSY 5245 Michael C. Rodriguez
Does Multilingualism Protect Against Alzheimer’s Disease
Friday Harbor Laboratory University of Washington August 27-31, 2006
Metacognitive Failure as a Feature of Those Holding Radical Beliefs
Presentation transcript:

Neuropathology and Cognitive Scores Workgroup The role of vascular and Alzheimer’s Disease pathology in differential cognitive impairment among older adults Bennett, Crane, Gavett, Farias, Jones, Mungas, & Yang March 27, 2009

Background Differentiating between AD and vascular pathologies pre-mortem is challenging. Several studies have suggested the two pathologies can be associated with different cognitive impairment profiles. Studies linking neuropsychological performance to dementia diagnosis that lack a gold-standard, such as neuropathological data, have limitations in making accurate predictions in live patients.

Purpose of the Study The study intends to examine the effects of specific neuropathology (AD and vascular pathology) on the global domain of cognitive impairment and on specific cognitive indicators by using the MIMIC model to: 1)determine whether the relationship between vascular- and AD-related cognitive impairment is unique, competitive, or synergistic; 2)determine the amount and type of vascular- and AD-related neuropathology in individual and overall cognitive measures.

Methods

Sample This study makes use of the data collected in the Religious Order Study (ROS), which began enrollment in There were 1,123 older nuns, priests, and brothers without known dementia at baseline from 40 groups across the US. The ROS investigators have achieved greater than 95% follow-up of survivors and greater than 95% autopsy rate among those eligible, with 450 brain autopsies. Analyses for this study used baseline measures of cognition derived from neuropsychological data further described below.

Measures Cognition. This study will include the following 17 separate cognitive functioning tests: Story A Immediate and Delayed, 48 East Boston Story Immediate and Delayed, 49 Word List Learning Trials, 50 Boston Naming Test, 51 Verbal Fluency, 52 Digit Forwards and Backwards, 48 Digit Ordering, Alphabetical Span, 56 Judgment of Line Orientation, 57 Number Comparison, 58 Standard Progressive Matrices, 59 and Symbol Digit Modalities Test. 60

Measures Episodic Memory. There were seven episodic memory tests included in this study. The first two tests were the Story A Immediate and Delayed Recall derived from the Logical Memory Test of the Weschler Memory Scales-Revised. Similar to the Story A test, the next two tests were the East Boston Story 49 Immediate and Delayed. The last three tests were the Word List Memory, World List Recall, and the Word List Recognition.

Measures Semantic Memory. In this study, we use the following two tests as semantic memory measures: the Boston Naming Test 51 and the Verbal Fluency test. 52 The Working Memory. The Digit Span Forwards (6 pairs of items) and the Digit Span Backward (6 pairs of items) that were administered and scored according to the Wechsler Memory Scale-Revised procedures. 48 The Digit Ordering 52 test was a variation of the Cooper and colleagues’ original version of the test. Similar to the Digit Ordering directions, the Alphabetical Span 56 was a task in which the participant were given two to eight words to sort in alphabetical order.

Measures Perceptual Speed. We included a timed and oral form of the Symbol Digit Modalities Test. 60 For the Number Comparison test, participants were asked to determine whether pairs of three to ten digit sequences were the same or different. 58 Visuospatial Abilities. For non-verbal intelligence visuospatial abilities, the Standard Progressive Matrices 59 were used that included 17 abstract visual display items that was lacking one element. The Judgment of Line Orientation 57 consisted of 15 different angles in a match-to-sample format that participants were asked to estimate.

Measures Brain autopsies were performed at predetermined sites using standard techniques. Vascular pathology. For these analyses, the vascular measures that we included were the following: all chronic macroscopic infarctions, ischemic lesions with small amounts of hemorrhage, the number of infarctions were coded as present (one or more infarctions) or absent, the location of infarctions as cortical or subcortical, frontal and non-frontal, and right and left. We also included lipohyalinosis 26 and amyloid angiopathy. AD pathology. The global measure of AD pathology

Statistical Analyses We used baseline data with continuous factor indicators and neuropathology scores. The multiple indicator, multiple causes (MIMIC) model, an extension of the confirmatory factor analytic model for dichotomous dependent variables with covariates was used at baseline, mid-wave follow-up, and the last neuropsychological assessment. We used the MIMIC model to determine differences in neuropsychological test performance on specific cognitive measures and composites, whole controlling for differing levels of global cognitive impairment.

MIMIC Model

Unidimensionality There were four residual correlations included in this initial model: the word list learning trials, the 3 minute delayed recall of words from the word list learning trials, and the multiple choice recognition task from the word list learning trials; logical memory immediate and delayed (Story A and East Boston Story); digit forward with digit backward. The fit of the model was  2= , df= 113, p<.001, CFI= 0.925, and an RMSEA= We then took the largest modification indices and correlated each pair of tests, until we derived the best fit model number: number comparisons with digit symbol timed test; digit forward with digit backward with alphabetical span; and line orientation with rate of progressive matrices (nonverbal intelligence visuospatial abilities). A sufficiently unidimensional model (  2 =455.47, df=109, p<.001, CFI=0.963, and an RMSEA=0.053) allowing a small number of residual correlations to account for some local dependencies (e.g., among word list learning trials).

Summary of Results